retatrutide dosing clinical trial Reta trial data & dosing — a must read Retatrutide (Reta) isn't just another GLP-1. It's a triple-agonist peptide Retatrutide Dosing: What You Need

The ongoing shortage of GLP-1 medications is placing an immense strain on the millions of Americans who have obesity, are looking for help, and cannot access the care that they deserve

Lancet 330(8571):13001304 Kushner RF, Calanna S, Davies M, Dicker D, Garvey WT, Goldman B et al (2020) Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5

Some individuals may use medication support to help: Because digestion, nutrient absorption, and medication response can change after bariatric surgery, combination approaches require careful medical supervision and individualized planning

They do not cause weight loss or improve blood sugar levels on their own